![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 27 January 2021
Sec. Cancer Molecular Targets and Therapeutics
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.583698
This article is part of the Research Topic Targeting the Microenvironment Niche in Hematologic Malignancies View all 17 articles
This article is a correction to:
CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma
A Corrigendum on
CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma
Song Y, Song W, Li Z, Song W, Wen Y, Li J, Xia Q and Zhang M (2020). Front. Oncol. 10:488. doi: 10.3389/fonc.2020.00488
In the original article, there was a mistake in Figure 3 and Figure 4 as published. In Figure 3, we put the wrong picture of EdU result in shNC group. In Figure 4B, we put the wrong picture of Apoptosis result in Control group. The correct Figure 3 and Figure 4 appear below. And in the Materials and Methods parts, we give a supplementary statement that cell lines used for Immunofluorescence were transfected with plasmid without GFP tag.
Figure 3 CDC27 influence the G1/S phase transition. (A, B) Cell proliferation were assessed by EdU incorporation assay. Data are representative of at least three independent experiments. **P < 0.01, *P < 0.05. (C, D) Flow cytometry was used to examine the cell cycle by PI staining of both Jurkat and Sup-T1 cells. Images and qualification of the cell cycle distribution in three independent experiments are shown. *P < 0.05, ***P < 0.001. N.S., not significant. (E, F) Western blot was performed to detect the expression levels of cell cycle related proteins in both Jurkat and Sup-T1 cells, respectively.
Figure 4 CDC27 inhibits cell apoptosis in T-LBL cells. (A, B) Flow cytometry was used to examine the apoptosis as the sum of both Q2 and Q4 quadrants (early + late apoptosis) by Annexin V/7-AAD staining of both Jurkat and Sup-T1 cells. Apoptosis rates were expressed as the mean (Q2 + Q4) ± SD of values from experiments performed in triplicate by using Student’s t-test. *P < 0.05, **P < 0.01. (C, D) Western blot was performed to detect the expression levels of apoptotic related proteins in both Jurkat and Sup-T1 cells, respectively.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: CDC27, T-cell lymphoblastic lymphoma, PD-L1, cell cycle, APC/C
Citation: Song Y, Song W, Li Z, Song W, Wen Y, Li J, Xia Q and Zhang M (2021) Corrigendum: CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma. Front. Oncol. 10:583698. doi: 10.3389/fonc.2020.583698
Received: 15 July 2020; Accepted: 29 September 2020;
Published: 27 January 2021.
Edited and reviewed by: Cirino Botta, Cosenza Hospital, Italy
Copyright © 2020 Song, Song, Li, Song, Wen, Li, Xia and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qingxin Xia, dHVkb3U0MTQxMzU0MDRAMTYzLmNvbQ==; Mingzhi Zhang, bWluZ3poaV96aGFuZzFAMTYzLmNvbQ==
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.